Nuclear calcium (Ca 2؉ ) regulates a number of important cellular processes, including gene transcription, growth, and apoptosis. However, it is unclear whether Ca 2؉ signaling is regulated differently in the nucleus and cytosol. To investigate this possibility, we examined subcellular mechanisms of Ca 2؉ release in the HepG2 liver cell line. The type II isoform of the inositol 1,4,5-trisphosphate (InsP 3) receptor (InsP 3R) was expressed to a similar extent in the endoplasmic reticulum and nucleus, whereas the type III InsP 3R was concentrated in the endoplasmic reticulum, and the type I isoform was not expressed. Ca 2؉ signals induced by low InsP3 concentrations started earlier or were larger in the nucleus than in the cytosol, indicating higher sensitivity of nuclear Ca 2؉ stores for InsP3. Nuclear InsP3R channels were active at lower InsP 3 concentrations than InsP3R from cytosol. Enriched expression of type II InsP 3R in the nucleus results in greater sensitivity of the nucleus to InsP 3, thus providing a mechanism for independent regulation of Ca 2؉ -dependent processes in this cellular compartment. 
) is a ubiquitous second messenger that regulates a wide range of activities in every type of cell. Its range includes such varied processes as secretion, contraction, metabolism, gene transcription, and apoptosis (1, 2) . It is not completely established how a single second messenger can coordinate such diverse effects within a single cell, yet there is increasing evidence that the spatial patterns of Ca 2ϩ signals may determine the specificity of these signals. Moreover, several lines of evidence (3) (4) (5) (6) suggest that increases in Ca 2ϩ in the nucleus have specific biological effects that differ from the effects of increases in cytosolic Ca 2ϩ . Studies in rat basophilic leukemia and HeLa cell lines suggest that nuclear Ca 2ϩ passively follows cytosolic Ca 2ϩ (7, 8) , although studies in Xenopus oocytes and in isolated hepatocyte nuclei suggest instead that nuclei are competent to generate their own Ca 2ϩ signals (9, 10) . Thus, it remains unclear whether or how Ca 2ϩ signaling within the nucleus is regulated.
Inositol 1,4,5-trisphosphate (InsP 3 ) receptors (InsP 3 R) are Ca 2ϩ -permeable channels in the endoplasmic reticulum (ER) that transduce a number of extracellular stimuli into cytosolic Ca 2ϩ (Ca i 2ϩ ) signals (2, (11) (12) (13) (14) . Three isoforms of the InsP 3 R have been described (13, 15) , each of which differs in its amino acid sequence, affinity for InsP 3 , and modulation by Ca i 2ϩ (16) (17) (18) (19) . It is postulated that differences in the subcellular distribution of these intracellular Ca 2ϩ channels shape the amplitude, duration, and wave patterns of Ca i 2ϩ transients in the cytosol (16, (20) (21) (22) (23) (24) .
Components necessary for InsP 3 -mediated Ca 2ϩ signaling are found not only in the cytosol, but in the nuclear membrane as well. The nuclear membrane contains phosphatidylinositol 4,5 bisphosphate (PIP 2 ), the precursor lipid of InsP 3 (25) , phospholipase C, the enzyme that hydrolyzes PIP 2 to InsP 3 and diacylglycerol (26) , InsP 3 3-kinase, the enzyme that phosphorylates InsP 3 to form InsP 4 (27) , and the InsP 3 R (28) (29) (30) (31) . Both the nuclear membrane facing the cytoplasm and the surface facing into the nucleus contain functional InsP 3 R (30, 32), suggesting that production of InsP 3 in the nucleus could lead to increases in Ca 2ϩ in the nucleus, independent of cytoplasmic Ca 2ϩ levels. Here, we examine whether Ca 2ϩ signaling in the nucleus and cytosol are differentially regulated, and whether such differences are related to the subcellular distribution of InsP 3 R isoforms.
Materials and Methods
Immunoblotting. An affinity-purified-specific rabbit polyclonal antiserum against the mouse type I InsP 3 R (directed against the 19 C-terminal residues; custom produced by Research Genetics, Huntsville, AL; characterized as described in ref. 33 ; diluted 1:500), an affinity-purified specific rabbit polyclonal antiserum against the rat type II InsP 3 R (directed against the C-terminal residues CG-FLGSNTPHENHHMPPH; characterized as described in ref. 34 ; diluted 1:200), and a monoclonal antibody against the human type III InsP 3 R (Transduction Laboratories, Lexington, KY; diluted 1:100; ref. 16 ) was used in this study. The expression of InsP 3 R isoforms in membrane fractions of the nucleus, ER, and in whole cells was monitored with immunoblotting with a 5% polyacrylamide gel and standard Western blotting techniques (16, 24, 35) .
Immunocytochemistry. Immunocytochemistry was performed as described (20, 36) . Cells were immersion-fixed on coverslips for 5 min in 4% (wt͞vol) paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4). Immunocytochemical labeling was carried out by using the indirect fluorescence method. After blocking in PBS (0.01 M, pH 7.4) containing 10% (vol͞vol) normal goat serum, 1% (vol͞vol) BSA, and 0.05% Triton X-100, the binding sites of the primary antibodies were revealed by secondary antibodies: goat anti-rabbit or goat anti-mouse IgG coupled to Alexa 488 (Molecular Probes; diluted 1:100). Primary and secondary antibodies were diluted in PBS containing 3% (vol͞ vol) normal goat serum, 1% (vol͞vol) BSA, and 0.05% Triton X-100. Controls in which the primary antibodies were omitted showed no specific staining. Cells were counterstained with propidium iodide (Sigma). Immunofluorescently labeled sections were examined and recorded by using a Zeiss LSM 510 laser scanning confocal microscope. Nuclear and cytosolic Ca 2ϩ were monitored in individual cells by using time-lapse confocal microscopy, as described (37, 38) . Imaging System. Changes in fluorescence intensity were calculated by dividing the measured fluorescence intensity during application of nucleotide or photorelease of InsP 3 (F) by the measured average baseline fluorescence intensity (F 0 ). Images were acquired every 150-600 msec. InsP 3 production through stimulation of P2Y ATP receptors was induced by bathapplication of ATP (1-100 M). Alternatively, some cells were microinjected with 1 mM nitrophenylethyl ester (NPE)-caged InsP 3 (Calbiochem). In these experiments, microinjection pipettes were loaded with the cell-impermeant form of fluo-3 (1 mM) along with caged InsP 3 to detect Ca 2ϩ and to verify successful injection. After injection, cells were allowed to recover for 5-10 min before flash photolysis studies were performed. Fluo-3 has a greater molecular weight than NPE-InsP3, so only those cells with uniform fluo-3 fluorescence in the nucleus and cytosol were used. NPE-InsP 3 was photolyzed by using a mercury arc lamp (50 W) coupled to a 1-mm quartz fiberoptic cable through a high-speed shutter and filter wheel (16) . Because the microinjection volume was Ͻ10% of the total cell volume, the maximum intracellular concentration of NPEInsP 3 was 100 M. Maximal uncaging occurred with flashes Ͼ300 msec in duration, so the concentration of free InsP 3 after an initial flash was estimated by (100 M) ϫ (flash duration)͞ (300 msec), up to a maximum of 100 M. The amount of InsP 3 liberated by subsequent flashes was determined by the same formula, but reducing the maximum releasable InsP 3 by the amount that already had been released. These estimates are similar to those described by others using similar techniques (39) .
Bilayer Experiments. Nuclei were separated from HepG2 cells by using a kit from Pierce. Brief ly, nuclear and ER membrane vesicles were isolated from the nuclear and cytoplasmic fractions, respectively, in the presence of protease inhibitors by differential centrifugation (40) . Vesicles were aliquoted and stored at Ϫ80°C until needed for experiments. InsP 3 Rs from nuclear or ER vesicles were incorporated into planar lipid bilayers containing phosphatidylethanolamine and phosphatidylserine (3:1 wt͞wt; Avanti Polar Lipids) dissolved in decane (40 mg of lipid per ml). The experiments were performed with Expression and subcellular distribution of InsP3R isoforms in HepG2 cells. (A) Immunoblot of whole-cell protein demonstrates that HepG2 cells express types II and III but not type I InsP 3Rs. Cerebellum, hepatocytes, and RIN-5F cells are used as isoform-specific controls for type I, II, and III InsP 3Rs, respectively. The entire lane of each blot is shown. (B) Immunoblot comparing cytosolic and nuclear membrane proteins demonstrates that the type II InsP 3R is expressed to a similar extent in both compartments, but the type III InsP 3R is relatively decreased in nucleus. Immunoreactive bands were detected at a molecular mass of 240 -260 kDa. (C) Densitometry confirms that the type II InP 3R is enriched in the nucleus relative to the type III isoform ( * , P Ͻ 0.025 based on n ϭ 4 blots).
(D) Demonstration of the purity of nuclear and cytosolic preparations. Parvalbumin was either targeted to the nucleus with an NLS sequence or excluded from the nucleus by using an NES sequence. NLS-parvalbumin was detected only in the nuclear fraction of HepG2 cells, whereas NES-parvalbumin was detected only in the cytosolic (nonnuclear) fraction. was used as the current carrier because it has been shown for InsP 3 Rs not to inf luence channel activity and to produce larger current amplitudes than Ca 2ϩ (41) . Channels were activated by the addition of Ca 2ϩ (300 nM, because this is the optimal concentration for InsP 3 R activity) and InsP 3 to the cis side. Demonstration of InsP 3 -dependent channel activity was taken as evidence for the presence of InsP 3 Rs in the bilayer. Channel activity was monitored over a range of InsP 3 concentrations on the cytosolic side of the channels. Experiments were recorded under voltage-clamp conditions, filtered at 1 kHz, digitized at 3 kHz, and transferred directly to a computer. The data were acquired, ana- Foster City, CA) . The data shown in the present study were obtained from three or more independent trials for each experimental condition.
Results and Discussion
InsP3R Subtypes Are Differentially Expressed in Nucleus and Cytosol.
We examined expression and subcellular localization of InsP 3 R isoforms in HepG2 cells by immunoblotting and confocal immunofluorescence. Immunoblotting of intracellular membrane preparations detected type II and III but not type I InsP 3 R (Fig. 1A) . Similar concentrations of the type II InsP 3 R were detected in HepG2 nuclei and ER, whereas the type III isoform was enriched 10-fold in ER relative to nuclei (P Ͻ 0.025; Fig. 1 B and C) . The purity of the nuclear and cytosolic fractions was confirmed by using cells transfected with a construct that targets parvalbumin to either the nucleus (NLS-PV) or cytosol (NES-PV; ref. 6). Targeted constructs were used because ER markers can be found in both cytosol and nucleus (42) . Parvalbumin immunoblots detected the protein in the nuclear but not the cytosolic fraction of NLS-PVtransfected cells, and in the cytosolic but not nuclear fraction of NES-PV-transfected cells (Fig. 1D) . Consistent with immunoblots, immunocytochemistry demonstrated strong type II InsP 3 R immunoreactivity in both the nuclear and cytosolic regions (Fig. 2 A-C) . Type II InsP 3 R antibodies occasionally decorated not only the cytosol and nuclear envelope (NE), but also other portions of the nuclear interior. These findings are consistent with previous observations that protrusions from the ER and NE extend into the nuclear interior in most cell types (42) . In contrast to the distribution of the type II InsP 3 R, type III InsP 3 R immunoreactivity was minimal in the nucleus (Fig. 2 D-F) . These findings are in agreement with studies that report differentially distributed InsP 3 R isoforms within substructures of the ER (20, 24, 35, 43, 44) and studies that describe the expression of specific InsP 3 R subtypes within the nuclear envelope (28, 45, 46) . In separate experiments, RT-PCR was performed by using primers to amplify a region common to all three isoforms of the ryanodine receptor (RyR) isoforms (47 were monitored in individual HepG2 cells by using time-lapse confocal microscopy ( Fig. 3 A and B Individual data points show the peak nuclear vs. cytosolic fluorescence (relative to baseline) in each of 60 observations. The identity line is shown for reference, to illustrate where data points would lie if nuclear and cytosolic fluorescence were equal. The regression curve for these data is: (% increase in cytosol) ϭ 1.27 ϫ (% increase in nucleus) Ϫ 39.2 (R 2 ϭ 0.92; P Ͻ 0.00001), which demonstrates that nuclear Ca 2ϩ increases more than cytosolic Ca 2ϩ for small Ca 2ϩ signals, but that cytosolic Ca 2ϩ increases more than nuclear Ca 2ϩ for larger Ca 2ϩ signals (main graph). Note that nuclear Ca 2ϩ signals predominate when the Ca 2ϩ transient is Ͻ140% of baseline (see Inset).
f luorescence intensity in the nucleus and cytosol (55, 57, 58) . Therefore, for these studies, nuclear and cytosolic Ca 2ϩ signals were normalized to the same baseline and peak value to focus on the temporal differences between the two tracings ( Fig. 3  C and D) . All cells tested (n ϭ 60 cells) responded to stimulation with 100 M ATP, whereas most (56 of 60 cells, or 93%) responded to 10 M ATP, and very few (13 of 70 cells, or 19%) responded to 1 M ATP. Therefore, we compared Ca 2ϩ signals in the nucleus and cytosol in cells stimulated with 10 or 100 M ATP (Fig. 3 C-E) . In cells stimulated with 10 M ATP (Fig. 3C) , nuclear Ca 2ϩ signals preceded cytosolic Ca 2ϩ signals by 449 Ϯ 91 msec (mean Ϯ SEM, n ϭ 16; P Ͻ 0.0001 by paired t test). In contrast, nuclear and cytosolic Ca 2ϩ signals began nearly simultaneously in cells stimulated with 100 M ATP (time difference, 0.0 Ϯ 0.8 msec; n ϭ 26; P ϭ 0.50 by paired t test; Fig. 3D ). This finding is similar to the observation that nuclear and cytosolic Ca 2ϩ signals begin simultaneously in primary hepatocytes stimulated with a maximal concentration of vasopressin (56) , which also increases Ca 2ϩ via InsP 3 (26) . Thus, although nuclear and cytosolic Ca 2ϩ signals are similar in maximally stimulated cells, differences during submaximal stimulation suggest that the threshold for InsP 3 -induced Ca 2ϩ signaling is lower in the nucleus than in the cytosol. To investigate this finding more directly, controlled amounts of InsP 3 were released in HepG2 cells by f lash photolysis of microinjected, caged InsP 3 while cells were observed with time-lapse confocal microscopy (Fig. 4) . Photorelease of smaller amounts of InsP 3 resulted in Ca 2ϩ signals that were greater in the nucleus than in cytosol (Fig. 4 A and C) . Photorelease of larger amounts of InsP 3 resulted in Ca 2ϩ signals that were greater in the cytosol (Fig. 4 B and C) . Together, these findings suggest that the nucleus has a lower threshold than the cytosol for InsP 3 -induced Ca 2ϩ signaling, which results in preferential signaling in the nucleus when cells are stimulated with submaximal concentrations of agonist.
The InsP3R of Nuclear and ER Membranes Behave Differently. To determine whether the observed differences between nuclear and cytosolic Ca 2ϩ signals could be attributed to differences in InsP 3 R isoforms, biophysical properties of InsP 3 Rs expressed in HepG2 nucleus and ER membranes were determined. Vesicles were prepared from nuclear and ER membranes, and singlechannel recordings of InsP 3 Rs present in these vesicles were performed. InsP 3 R channels from both nuclei and ER could be activated by the addition of physiological concentrations of InsP 3 to their cytosolic side (Fig. 5A Middle) , similar to the type I (59), type II (18, 60) , and III InsP 3 Rs (16). Channel inactivation by heparin was used to verify that HepG2 Ca 2ϩ channels had typical InsP 3 R pharmacology (Fig. 5A Bottom) . Nuclear Ca 2ϩ channel activity was initiated by InsP 3 concentrations of 10 nM and greater, and increasing InsP 3 concentrations stimulated higher channel activity (Fig. 5B) In contrast, ER channels are not active until they are above 1 M InsP3, when they also reach a plateau. Regression analysis of ER InsP 3R activity dependence on the InsP 3 concentration shows half-maximal activity at 3.7 M InsP3. This figure shows the normalized open probability (P0) for ER and nuclear InsP3Rs; the absolute P0 using 100 M InsP3 is 7.4% and 2.9% for ER and nuclear receptors, respectively. The averages of at least three single-channel experiments and their SEs are shown for each data point.
initiated unless cytosolic InsP 3 concentrations exceeded 1 M (Fig. 5 C and D) . Half-maximal activation occurred at 3.7 M InsP 3 , a value significantly higher than that described for type II InsP 3 (18, 60) . Together, these findings suggest that nuclear expression of the type II InsP 3 R isoform may be responsible for the preferential Ca 2ϩ signaling that occurs in the nucleus of HepG2 cells.
The subcellular pattern of Ca 2ϩ signals is an important component of how this second messenger regulates cell function. For example, presynaptic increases in Ca 2ϩ regulate neurotransmitter release (66) , Ca 2ϩ gradients direct cell movement (67, 68) , and Ca 2ϩ waves may direct morphogenesis (69) . The three InsP 3 R isoforms each behave in a distinct fashion, both at the single-channel level (16, 60) and in intact cells (21) . Therefore, it has been proposed that the subcellular distribution of each isoform helps shape the subcellular pattern of Ca 2ϩ signals in the cytosol (16, 24, 44) . However, elevations in nuclear rather than cytosolic Ca 2ϩ are required for some processes, such as transcription of certain genes (4) (5) (6) . In addition, the nucleus contains its own InsP 3 -sensitive Ca 2ϩ stores, within the nuclear envelope (30) . The current work provides a mechanism for regulation of the Ca 2ϩ concentration in the nucleus independent of changes in cytosolic Ca 2ϩ (Figs. 3 and 4; refs. 9 and 70) . The findings of the present study support the idea of an independent regulation of intracellular Ca 2ϩ changes based on compartmentspecific, differential distribution of intracellular Ca 2ϩ channels with different biophysical properties. Specificity in the subcellular distribution and modulation of the InsP 3 R isoforms in nucleus and cytosol may be the mechanism used by many cell types to coordinate and independently regulate nuclear and cytosolic processes.
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